home / stock / nxgl / nxgl news

NXGL News and Press, NexGel Inc From 04/18/24

Stock Information
Company Name: NexGel Inc
Stock Symbol: NXGL
Market: NASDAQ
Website: nexgel.com
Menu
NXGL NXGL Quote NXGL Short NXGL News NXGL Articles NXGL Message Board
Get NXGL Alerts

News, Short Squeeze, Breakout and More Instantly...
NXGL - NEXGEL to Present at the Planet MicroCap Showcase: VEGAS 2024, May 1 & 2, 2024

LANGHORNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consu...
NXGL - NEXGEL, Inc. (NXGL) Q4 2023 Earnings Call Transcript

2024-04-01 14:25:25 ET NEXGEL, Inc. (NXGL) Q4 2023 Earnings Conference Call April 1, 2024 08:30 ET Company Participants Valter Pinto - Managing Director, KCSA Strategic Communications Adam Levy - Chief Executive Officer Adam Drapczuk - Chief Financial Officer ...

NXGL - NEXGEL reports Q4 results

2024-04-01 10:14:56 ET More on NEXGEL Seeking Alpha’s Quant Rating on NEXGEL Historical earnings data for NEXGEL Read the full article on Seeking Alpha For further details see: NEXGEL reports Q4 results

NXGL - NEXGEL Reports Full Year 2023 Revenue of $4.1 Million, an Increase of 99.7% Year-Over-Year

LANGHORNE, Pa., April 01, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced its financia...
NXGL - Expected US Company Earnings on Monday, April 1st, 2024

GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...

NXGL - NEXGEL Reschedules Fourth Quarter and Full Year 2023 Financial Results Conference Call to Monday, April 1st at 8:30 a.m. ET Due to Holiday

LANGHORNE, Pa., March 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare a...

NXGL - NEXGEL to Report Fourth Quarter and Full Year 2023 Financial Results on March 28th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., March 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC)...
NXGL - NEXGEL to Present at the iAccess Alpha Best Ideas Spring Virtual Conference on March 12th

LANGHORNE, Pa., March 04, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consu...

NXGL - NEXGEL Announces $975,000 Registered Direct Offering Led by Insiders

LANGHORNE, Pa., Feb. 21, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...

NXGL - NEXGEL to Present at The Microcap Conference, January 30th through February 1st

LANGHORNE, Pa., Jan. 18, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that Adam Lev...
Previous 10 Next 10